125 related articles for article (PubMed ID: 4663825)
21. A further study of catecholamine omicron-methylation in schizophrenia.
Wagner AF; Cirillo VJ; Meisinger MA; Ormond RE; Kuehl FA; Brink NG
Nature; 1966 Aug; 211(5049):604-5. PubMed ID: 5968726
[No Abstract] [Full Text] [Related]
22. Symposium on catecholamines and their enzymes in the neuropathology of schizophrenia. Epilogue.
Matthysse S
J Psychiatr Res; 1974; 11():xiii-xvi. PubMed ID: 4618284
[No Abstract] [Full Text] [Related]
23. Neurobiology of dopamine in schizophrenia.
Guillin O; Abi-Dargham A; Laruelle M
Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
[TBL] [Abstract][Full Text] [Related]
24. A critique of the dopamine hypothesis of schizophrenia and psychosis.
Moncrieff J
Harv Rev Psychiatry; 2009; 17(3):214-25. PubMed ID: 19499420
[TBL] [Abstract][Full Text] [Related]
25. Biochemical correlates of schizophrenia.
Malek-Ahmadi P; Fried FE
Compr Psychiatry; 1976; 17(4):499-509. PubMed ID: 61095
[No Abstract] [Full Text] [Related]
26. [New pharmacological approaches to the treatment of schizophrenia].
Uzbay IT
Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
[TBL] [Abstract][Full Text] [Related]
27. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
Goto Y; Grace AA
Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
[TBL] [Abstract][Full Text] [Related]
28. The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system.
Youdim MB; Yehuda S
Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):491-500. PubMed ID: 10872737
[TBL] [Abstract][Full Text] [Related]
29. Integrating the neurobiology of schizophrenia. Preface.
Abi-Dargham A; Guillin O
Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
[No Abstract] [Full Text] [Related]
30. [Schizophrenia and cerebral amines].
Véron JP; Kezirian S
Presse Med (1893); 1971 Oct; 79(44):1973-4. PubMed ID: 5119550
[No Abstract] [Full Text] [Related]
31. Interaction between N-methyl-D-aspartic acid receptors and D1 dopamine receptors: an important mechanism for brain plasticity.
Scott L; Aperia A
Neuroscience; 2009 Jan; 158(1):62-6. PubMed ID: 19000746
[TBL] [Abstract][Full Text] [Related]
32. Schizophrenia.
Morrison PD; Murray RM
Curr Biol; 2005 Dec; 15(24):R980-4. PubMed ID: 16360673
[No Abstract] [Full Text] [Related]
33. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin.
Kumamoto N; Matsuzaki S; Inoue K; Hattori T; Shimizu S; Hashimoto R; Yamatodani A; Katayama T; Tohyama M
Biochem Biophys Res Commun; 2006 Jun; 345(2):904-9. PubMed ID: 16701550
[TBL] [Abstract][Full Text] [Related]
34. Parasitosis, dopaminergic modulation and metabolic disturbances in schizophrenia: evolution of a hypothesis.
Treuer T; Martenyi F; Karagianis J
Neuro Endocrinol Lett; 2007 Oct; 28(5):535-40. PubMed ID: 17984933
[TBL] [Abstract][Full Text] [Related]
35. Alterations of dopamine and serotonin transmission in schizophrenia.
Remington G
Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
[TBL] [Abstract][Full Text] [Related]
36. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Lideman RR; Zlobina GP; Mukhin AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
[No Abstract] [Full Text] [Related]
37. [Clinical studies on urinary vanillylmandelic acid in various endocrine diseases. II. Clinical studies on urinary vanillylmandelic acid in patients with thyroidal diseases, those with pheochromocytoma, those with pituitary-adrenocortical and related diseases and those with diabetes mellitus].
Ezaki T
Naika Hokan; 1966 Jan; 13(1):23-45. PubMed ID: 5948572
[No Abstract] [Full Text] [Related]
38. Therapeutic possibilities of cysteamine in the treatment of schizophrenia.
Pae CU; Lee C; Paik IH
Med Hypotheses; 2007; 69(1):199-202. PubMed ID: 17166669
[TBL] [Abstract][Full Text] [Related]
39. Evolution of schizophrenia drugs: a focus on dopaminergic systems.
Nikam SS; Awasthi AK
Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530
[TBL] [Abstract][Full Text] [Related]
40. [Schizophrenia].
Guilmot PH
Brux Med; 1972 Nov; 52(11):749-53. PubMed ID: 4654572
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
